FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| METHOTREXATE SODIUM | 63323-122-50 | Fresenius Kabi USA, LLC | ANDA040266 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 75840-111-01 | GenPak Solutions LLC | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-530-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 70518-3672-0 | REMEDYREPACK INC. | ANDA210454 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 59137-505-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 81927-204-01 | SHORLA ONCOLOGY INC. | NDA212479 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 71335-2221-4 | Bryant Ranch Prepack | ANDA210454 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 59137-520-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 16729-277-30 | Accord Healthcare, Inc. | ANDA040716 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 50268-527-11 | AvPAK | ANDA210040 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 42291-505-01 | AvKARE | ANDA210040 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 51079-670-05 | Mylan Institutional Inc. | ANDA081235 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-025-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-012-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-350-10 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 71335-2221-3 | Bryant Ranch Prepack | ANDA210454 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 66336-338-30 | Dispensing Solutions, Inc. | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 0703-3678-01 | Teva Parenteral Medicines, Inc. | ANDA040843 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 71335-1772-3 | Bryant Ranch Prepack | ANDA213343 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 16729-277-35 | Accord Healthcare, Inc. | ANDA040716 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 59137-540-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-540-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 0143-9516-01 | Hikma Pharmaceuticals USA Inc. | ANDA089343 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-010-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 71335-1118-3 | Bryant Ranch Prepack | ANDA081235 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-015-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 0378-0014-01 | Mylan Pharmaceuticals Inc. | ANDA081235 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-015-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-520-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-530-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-
